Pain-management clinics may receive enquiries about hyperbaric oxygen therapy, but persistent pain is complex and requires appropriate assessment. A responsible discussion starts with the person’s diagnosis, symptom pattern, current care plan and the clinical question being considered.
In some clinical pathways, HBOT may be considered in relation to an underlying condition; in others, the evidence may not support a role. It should not be presented as a universal or stand-alone answer for pain.
Any chamber-based clinical pathway should sit within multidisciplinary care and be determined by appropriately qualified professionals. Origin Oxygen products supplied for general wellbeing are distinct from clinical HBOT, and research findings do not automatically apply to them.
Where HBOT May Be Considered
Consideration should begin with a clear diagnosis and an evidence-aware care plan rather than a broad claim about chronic pain. The clinic should define the clinical context, screening criteria, referral arrangements and the specific question the clinical team is trying to address.
Where a clinician considers a hyperbaric pathway relevant, goals should be realistic and measurable. Suitability and outcomes vary between individuals, and the intervention should remain connected to the person’s wider plan.
Integrated Pain Care
A chamber-based clinical pathway should not replace established assessment or multidisciplinary support. The source material places emphasis on coordination with relevant medical care, medication review where appropriate, movement and rehabilitation support, psychological approaches and specialist referral.
Shared decision-making should include balanced information about the proposed purpose, alternatives, uncertainties and potential risks. Progress should be reviewed against agreed functional goals rather than assumed from attendance at sessions.